Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 897,17 €, with a 24-hour trading volume of 2,94B €. The asset's market cap is 802,99B €, after moving -1.11% in the last day.
Tokenized Eli Lilly And Co is trading at 895,46 €, with a tokenized market cap of 4,78M € and a 24-hour trading volume of 1,77M €. The tokenized asset has moved -1.23% in the past 24 hours.